➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Merck
Johnson and Johnson
Medtronic
McKesson
McKinsey

Last Updated: July 9, 2020

DrugPatentWatch Database Preview

Patent: 6,090,777

» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 6,090,777
Title: Method to reduce myocardial injury during acute myocardial infarction
Abstract:A therapeutic or prophylactic treatment method of acute myocardial infarction, comprising administering exogenous C1-esterase inhibitor, alone or in combination with other drugs, to a patient with acute myocardial infarction or to a patient at risk for acute myocardial infarction. The treatment inhibits the inflammatory reaction, more specifically the activation of the complement system, which occurs in the course of acute myocardial infarction. The C1-esterase inhibitor may include C1-esterase inhibitor purified from plasma or other biological materials, or recombinant C1-esterase inhibitor, or recombinant variants derived therefrom, or recombinant constructs of other inhibitors having a specificity similar to C1-esterase inhibitor.
Inventor(s): Hack; Cornelis Erik (Diemen, NL), Hermens; Willem Theodoor (Gronsveld, NL)
Assignee: Stiching Centraal Laboratorium Van de Bloedtransfusiedienst Van Het (Amsterdam, NL)
Application Number:08/604,933
Patent Claims:see list of patent claims

Details for Patent 6,090,777

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Bioconnection B.v. RUCONEST c1 esterase inhibitor recombinant INJECTION, POWDER, FOR SOLUTION 125495 1 2014-09-22   Start Trial Stiching Centraal Laboratorium Van de Bloedtransfusiedienst Van Het (Amsterdam, NL) 2013-09-01 search
Microbix Biosystems KINLYTIC urokinase INJECTABLE;INJECTION 021846 003 1978-01-16   Start Trial Stiching Centraal Laboratorium Van de Bloedtransfusiedienst Van Het (Amsterdam, NL) 2013-09-01 DISCN search
Microbix Biosystems KINLYTIC urokinase INJECTABLE;INJECTION 021846 002 1978-01-16   Start Trial Stiching Centraal Laboratorium Van de Bloedtransfusiedienst Van Het (Amsterdam, NL) 2013-09-01 DISCN search
Microbix Biosystems KINLYTIC urokinase INJECTABLE;INJECTION 021846 001 1978-01-16   Start Trial Stiching Centraal Laboratorium Van de Bloedtransfusiedienst Van Het (Amsterdam, NL) 2013-09-01 DISCN search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Harvard Business School
Medtronic
McKinsey
Mallinckrodt
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.